Nasal Spray Alternative To Epipen For Allergic Reactions Is Approved By Fda

FDA approves EpiPen alternative: a nasal spray for anaphylaxis

Neffy, the new nasal spray for severe allergic reactions, is now available in the US

The FDA has approved Neffy, the first nasal spray epinephrine drug for the treatment of anaphylaxis

The US Food and Drug Administration (FDA) has approved the first nasal spray epinephrine drug for the treatment of anaphylaxis. Neffy, made by ARS Pharmaceuticals, is a needle-free alternative to EpiPen and other injectable epinephrine auto-injectors.

Anaphylaxis is a severe, life-threatening allergic reaction that can be caused by insect stings, foods, medications, and other allergens. Symptoms of anaphylaxis can include difficulty breathing, swelling of the throat and face, hives, and nausea.

Epinephrine is a hormone that can help to open up the airways and reduce swelling. It is typically injected into the thigh using an auto-injector.

Neffy is a nasal spray that delivers epinephrine directly to the nasal cavity. This can be an advantage for people who are afraid of needles or who have difficulty using auto-injectors.

In clinical trials, Neffy was found to be as effective as EpiPen in treating anaphylaxis. It was also well-tolerated, with few side effects.

The FDA's approval of Neffy is a significant step forward in the treatment of anaphylaxis. It provides a new, needle-free option for people who are at risk for this life-threatening condition.